Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Locobase is a high-lipid emollient and barrier-repair cream designed for the management of very dry, sensitive, and diseased skin, particularly in conditions such as psoriasis and atopic dermatitis. The formulation is characterized by a high lipid content (typically around 70%) and includes skin-identical lipids such as ceramides, cholesterol, and free fatty acids. These components work by creating an occlusive layer on the skin surface to reduce transepidermal water loss (TEWL) and by integrating into the stratum corneum to restore the skin's natural barrier function. Originally developed by Yamanouchi (which later merged into Astellas), the brand is frequently used in clinical research as a baseline therapy or supportive treatment to improve skin plasticity and hydration. It is currently marketed in various regions by companies including Karo Healthcare.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Locobase.